What B Corp Certification Actually Means for a Biotech Supplier

B Corp is everywhere. But what does it mean upstream?

Most coverage of B Corp certification focuses on consumer brands: coffee roasters, skincare lines, fashion labels. What receives far less attention is what the certification process looks like when the company in question operates upstream, at the beginning of the value chain, with no consumer-facing products.

BotaniX cultivates medicinal plants under controlled aeroponic conditions and supplies pharmaceutical-grade botanical raw materials to research centres, cosmetics formulators, and nutraceutical manufacturers. We have no retail presence. No packaging to redesign. Yet when B Lab assessed our operations, the process was as rigorous as for any consumer company, and in some areas more so, because of the complexity and opacity typical of upstream supply chains.

We have held B Corp certification since November 2022, with an overall B Impact Score of 96.6, nearly double the 50.9 median for businesses that complete the assessment. The full breakdown of our score is publicly available on the B Corp directory.

What the assessment actually examines

B Corp certification is administered by B Lab, a global non-profit that evaluates companies across five impact areas: governance, workers, community, environment, and customers. The process includes documentation review, interviews, and on-site verification. It is not a self-declaration. A company must score at least 80 points out of 200 on the B Impact Assessment to qualify.

For a company like ours, several dimensions are especially relevant. Environmental impact is assessed through resource consumption, waste generation, and ecological footprint. Our aeroponic model recycles over 90 per cent of water, uses zero pesticides, operates on 100 per cent co-generation energy, and produces no chemical effluent. These are measured operational outcomes, not pledges.

Worker welfare is evaluated against employment practices, compensation, and safety. Community impact examines local engagement, supplier relationships, and knowledge contribution. Governance looks at transparency, stakeholder consideration, and mission integration. Each area requires documented evidence, not policy statements.

Aeroponics changes the equation

In an aeroponic system, roots grow freely in air. They are fully visible, fully accessible, and can be harvested without damage or contamination. Because there is no soil to extract them from, the root biomass arrives clean, intact, and ready for processing. This fundamentally transforms what is possible with root-derived botanical ingredients.

This opens up three capabilities that conventional cultivation simply cannot match.

First, root biomass can be harvested independently from the aerial parts, allowing separate processing and analysis of root-specific compound profiles. A single plant can yield two distinct ingredient streams, each with its own phytochemical identity and application potential.

Second, the absence of soil means root material is pristine from the moment of harvest, dramatically reducing post-harvest processing requirements and preserving sensitive compounds that might be degraded during extensive washing and cleaning steps.

Third, because the entire root system develops in a controlled environment with defined nutrient inputs and growth conditions, root morphology and biochemical content are far more consistent than wild-harvested or field-grown equivalents. This consistency is the foundation for standardized, reproducible ingredient specifications.

Beyond ESG metrics: why it matters for B2B buyers

B Corp certification is not a product quality certification. It does not replace ANSM accreditation, which validates BotaniX as a supplier of starting materials for clinical trials, nor does it replace ISO 16128 compliance or Nagoya Protocol adherence. We maintain each of these independently. What B Corp does is confirm, through independent external audit, that the company producing those materials operates responsibly across its operations. For B2B buyers, the EU Corporate Sustainability Reporting Directive now requires companies to document and disclose the sustainability performance of their supply chains. For procurement teams managing dozens of botanical ingredients from multiple geographies, a B Corp-certified supplier at the origin of the chain provides defensible, third-party-verified documentation that supports CSRD reporting obligations.

The term "pharmaceutical-grade" is used broadly across the botanical supply industry, but the operational infrastructure behind that claim varies widely between suppliers. Some companies use it as a marketing descriptor. Others back it with audited quality systems, batch documentation, regulatory accreditation, and independent certification. B Corp does not evaluate product quality directly, but it evaluates the governance, transparency, and operational rigour of the company making the claim, and the results are public.

A signal of operational maturity

For investors conducting due diligence on early-stage biotech companies, B Corp certification provides an independently verified data point. It indicates that the company has already built the documentation systems, governance frameworks, and sustainability infrastructure that later-stage companies often struggle to retrofit. In a sector where many early-stage companies rely on narrative rather than evidence, a score of 96.6 from a recognised external assessor reflects operational maturity that pitch decks alone cannot demonstrate.

Stricter standards ahead

B Lab overhauled its standards in 2025, replacing the flexible points-based system with mandatory minimum requirements across seven impact topics, including climate action, human rights, and environmental stewardship. Companies recertifying from 2026 onward must meet these stricter baselines in every area and demonstrate measurable improvement over a five-year cycle. The old model allowed companies to offset weak areas with strong ones. The new framework does not. For BotaniX, this evolution reinforces our position. The operational practices that earned our 96.6 score, from co-generation energy and closed-loop water systems to full batch traceability and zero-pesticide cultivation, align with where the new standards are heading. Recertification under the stricter framework will confirm that our sustainability performance is structural, not cosmetic. See more about us on the B Corp website.

Yishai Nissan is Co-Founder and COO of BotaniX, a B Corp-certified producer of pharmaceutical-grade botanical ingredients based in France.

Discover our plant catalog